About Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) is a rare disease catalogued by Orphanet (ORPHA:402020). It is associated with the MECOM, RPN1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) trials.
Search ClinicalTrials.gov for "Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)" or filter by Orphanet code ORPHA:402020 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2). Updated daily.